MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Highlighting the spectrum of practice in the routine management of cervical dystonia with botulinum neurotoxin-A: Baseline injection practice data from MetaCD

    R. Trosch, V.P. Misra, S. Om, P. Maisonobe (Farmington Hills, MI, USA)

    Objective: To describe the spectrum of routine injection practice for botulinum neurotoxin-A (BoNT-A) in the management of cervical dystonia (CD). Background: The success of each…
  • 2016 International Congress

    How satisfied are cervical dystonia patients with their botulinum toxin treatment? Findings from an international observational study

    V.P. Misra, C. Colosimo, D. Charles, T.M. Chung, P. Maisonobe, S. Om (London, United Kingdom)

    Objective: Evaluate patient satisfaction with botulinum neurotoxin-A (BoNT-A) treatment over an injection cycle in routine practice. Background: Benefits of BoNT-A injection in cervical dystonia (CD)…
  • 2016 International Congress

    AbobotulinumtoxinA for cervical dystonia: International treatment patterns

    T.M. Chung, C. Colosimo, V.P. Misra, D. Charles, P. Maisonobe, S. Om (São Paulo, Brazil)

    Objective: To characterise international dosing practice for abobotulinumtoxinA (Dysport®, ABO) for cervical dystonia (CD) in a large observational study. Background: The safety and efficacy of…
  • 2016 International Congress

    DBS outcomes in a mixed cohort of dystonia: A single center experience

    O. Saeed, I. Haq, S.B. Tatter, A.W. Laxton, T. Wilson, M. Siddiqui (Winston Salem, NC, USA)

    Objective: To evaluate the efficacy and complications of deep brain stimulation (DBS) of globus pallidus interna (GPi) in a mixed cohort of dystonia patients. Background:…
  • 2016 International Congress

    Efficacy and safety of abobotulinumtoxinA in craniocervical dystonia and hemifacial spasm

    A. Jesic, D. Stefanovic, N. Delibasic, J. Radanov, M. Cvijanovic (Victoria, Seychelles)

    Objective: The aim of this paper was to analyze efficacy and safety of abobotulinumtoxinA (A/Abo), and compare them between the groups of patients with CD…
  • 2016 International Congress

    Phenomenology of idiopathic adult-onset truncal dystonia

    D.J. Ehrlich, S.J. Frucht (New York, NY, USA)

    Objective: Characterize the phenomenology and natural history of adult onset idiopathic truncal dystonia. Background: Focal dystonias are the most common type of adult-onset dystonia, however,…
  • 2016 International Congress

    Multicentre retrospective chart review of patients treated with incobotulinumtoxinA to evaluate sustained efficacy and tolerability in converted and de-novo conditions

    M.S. Jog, R.M. Jog, A. Tewari, D. Hobson, D. Stewart, D. King (London, ON, Canada)

    Objective: This study aimed to determine whether IncobotulinumtoxinA (IBTX) provides sustained efficacy as a treatment modality patients in both de-novo patients and patients converted from…
  • 2016 International Congress

    Cervical dystonia and quality of life

    S. Tomic, I. Petkovic, T. Pucic, S. Juric, S. Butkovic Soldo (Osijek, Croatia)

    Objective: To evaluate appearance of depression and anxiety in patiens with cervical dystonia and influence of dystonia symptoms on the quality of life. Background: Cervical…
  • 2016 International Congress

    DYT16/PRKRA founder mutation causes childhood-onset generalized dystonia in a family from southern Italy

    M. Quadri, S. Olgiati, M. Sensi, F. Gualandi, E. Groppo, V. Rispoli, J. Graafland, G.J. Breedveld, G. Fabbrini, A. Berardelli, V. Bonifati (Rotterdam, Netherlands)

    Objective: To describe a family with three siblings affected by the combination of dystonia and parkinsonism, as a resulting phenotype of recessive PRKRA mutation. Background:…
  • 2016 International Congress

    Endoscopic-guided injection of botulinum toxin into the longus capitis muscle and into the obliquus superior part of the longus colli muscle in dystonic antecaput

    G. Reichel, A. Stenner, H. von Sanden, L. Herrmann, C. Feja, S. Löffler (Zwickau, Germany)

    Objective: Cervical dystonia is the most commonly described dystonia. Since examinations of the muscle using imaging techniques were started [1], the classification of the phenomenological…
  • « Previous Page
  • 1
  • …
  • 1681
  • 1682
  • 1683
  • 1684
  • 1685
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley